Skip to Content

New Drug Approvals Archive - August 2002

See also: New Indications and Dosage Forms for August 2002

August 2002

Lexapro (escitalopram oxalate) Tablets and Oral Solution

Date of Approval: August 14, 2002
Company: Allergan, Inc.
Treatment for: Depression, Generalized Anxiety Disorder

Lexapro (escitalopram oxalate) is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder and for the treatment of generalized anxiety disorder (GAD).

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.